LONDON - eTradeWire -- The Wearable Injectors and Connected Devices Conference 2021 will consider key developments in the wearable injectors field, including the enhanced demand for on-body injectors and digitalised health as the pandemic highlights the need for self-administered at-home care, managing sustainability in the field, and opportunities for development in oncology.

This conference will bring together expertise from individuals in multiple disciplines in the field addressing key drivers of the market including large volume delivery, user-centric self-administration, and digital applications for an enhanced user interface.

You can view the two-day agenda and speaker programme on the event website:
www.wearable-injectors.co.uk/PRLOGPR2.

One of the key topics that will be addressed is: Device Design, Development and A Patient Centric Approach

Considerations for product development in Connected Health:

• Future trends in connected health
• Outlook for connected devices
• Exploring the ecosystem in healthcare
• User Experience
• Improving the entire patient journey using digital technology
• Setting up a connected eco-system
• Practical considerations for implementation
• Exploring technical and regulatory aspects needed for success

Daniel Latham, Head of Connected Health Product Development, Novartis

More on eTradeWire News

• VanBlaisa Pty Ltd Officially Incorporated, Marking New Chapter for Tasmanian Technology Company
• Hope Junkie Studios Named Among the Best Sober Clothing Brands in 2026
• 06 Members INC Announces Digital Expansion and New Creative Initiatives for Hip-Hop Artist MJ0.6
• LEDI Rallies Community Support to Complete $150K Fundraising Goal for Global Literacy
• A Platypus, a Childhood Nickname, and a family secret walk into a Children's book

Human Factors Patch Pump Pipeline Planning:

• Forming a platform HF strategy
• Gather inputs: Device competitive intelligence and analysis of known use problems
• Assessing the potential users in your pipeline
• Leveraging existing development activities to gain additional insights

Tiffany McIntire, Senior Human Factors Engineer, Roche
Flavia Pircher, Human Factors Engineer, Roche

Considerations for early technology evaluation and selection of large-volume, on-body injectors:

• Patient-centric evaluation: incorporating early human factors evaluations to inform use case boundaries.
• Technical approaches to maximize characterization when drug product is scarce or unknown
• Balancing use, technical, and manufacturing trade-offs in technology selection

Megan Heft, Engineering Manager, Device Development, AstraZeneca

The power of collaboration to deliver sustainable healthcare:

• The presentation will outline how the Sustainable Healthcare Coalition, a partnership of leading companies and public sector agencies, addresses some of the most pressing sustainability issues in global healthcare.
• Case studies of digital approaches and connected devices will demonstrate how healthcare sector industry partners can help the NHS achieve NetZero and bring together clinicians and industry to meet the challenges of improving sustainability through innovation.

Fiona Adshead, Chair, Sustainable Healthcare Coalition

More on eTradeWire News

• Acclaimed Short Film Flowerz, Written And Directed By Crystal Manning, Earns Prestigious Nomination
• Vytala Wins Startup World Cup Orange County Regional, Advances to Compete for $1 Million
• The Pulse of Entertainment: Billboard Chart-Topping Shyra Sanchez Releases New Single
• A Lone Star Take on a Modern Country Favorite Reaches Commercial FM Radio
• Developer Offers Free Website Checker to Help Australian Businesses Improve Their Websites

Register online at www.wearable-injectors.co.uk/PRLOGPR2. Register by 30^th June 2021 to save 200.

Proudly sponsored by: Quantex-arc and Avery Dennison Medical

Wearable Injectors and Connected Devices:
18^th – 19^th October 2021
Venue: Copthorne Tara Hotel
Scarsdale Place, Kensington, London, United Kingdom
(Virtual Attendance Option Available)

--- ENDS ---